Elixir Medical Corporation
Medical Equipment ManufacturingCalifornia, United States51-200 Employees
Elixir Medical Corporation is a mid-sized medical device manufacturer based in Milpitas, California, focused on advancing care for heart and vascular disease through innovation. Since 2005, it has pursued improved treatments for vascular disease by developing drug-eluting coronary stent systems, fully resorbable drug-eluting scaffolds, and bioadaptor systems, with its DynamX Coronary Bioadaptor System positioned as a next step beyond traditional drug-eluting stents. The company's work is oriented toward devices that aim to save lives and support patients' daily lives, rather than solely improving a device's technical performance. Its products target interventional cardiology practices and hospitals treating vascular conditions, addressing limitations of existing therapies and seeking better long-term outcomes for patients. In 2025, Elixir Medical expanded its portfolio with the LithiX Hertz Contact intravascular lithotripsy system, receiving CE Mark in Europe and subsequently launching the system commercially; the company also reported study results at the Transcatheter Cardiovascular Therapeutics conference.